Stem Cell-Derived Blood Products for Therapeutic Use: Technology Improvement (R43/R44)

Funding Opportunity Number: RFA-HL-15-030 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.839Eligible Applicants Small businessesAgency Name: HHS-NIH11Closing Date: Feb 20, 2017Award Ceiling: Expected Number of Awards: Creation Date: Nov 07, 2014Funding Opportunity Description: The primary objective of this funding opportunity announcement is to support the development of improved techniques and tools to enhance the production of clinically-relevant, functional stem cell-derived red blood cells or platelets in a more efficient and cost-effective manner. The research supported will develop and enhance technologies that enable the production of functional stem cell-based therapies with potential commercial and clinical viability.
Source: Grants.gov - Category: Research Tags: Health Source Type: funding